SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009606
Filing Date
2023-03-24
Accepted
2023-03-24 08:21:53
Documents
16
Period of Report
2023-03-24
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K impl-20230324.htm   iXBRL 8-K 72135
2 EX-99.1 impl-ex99_1.htm EX-99 564381
3 GRAPHIC img155103045_0.jpg GRAPHIC 96822
4 GRAPHIC img155103045_1.jpg GRAPHIC 70042
5 GRAPHIC img155103045_2.jpg GRAPHIC 70042
  Complete submission text file 0000950170-23-009606.txt   1121040

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230324.xsd EX-101.SCH 2459
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230324_lab.xml EX-101.LAB 19074
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230324_pre.xml EX-101.PRE 12029
10 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230324_htm.xml XML 5109
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 8-K | Act: 34 | File No.: 001-40353 | Film No.: 23757734
SIC: 2834 Pharmaceutical Preparations